Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay S Raval

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Apheresis|June 19, 2026
Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution UseJennifer M Jones, Fatima Aldarweesh, Nicole Aqui, et al.
JAMA|October 12, 2023
Red Blood Cell Transfusion: 2023 AABB International GuidelinesJeffrey L Carson, Simon J Stanworth, Gordon Guyatt, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Annals of Internal Medicine|August 18, 2025
Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice GuidelinesMonica B Pagano, Simon J Stanworth, Jane Dennis, et al.
Journal of Clinical Apheresis|March 27, 2025
A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021Jeremy W Jacobs, Brian D Adkins, Garrett S Booth, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Apheresis|June 19, 2026
Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution UseJennifer M Jones, Fatima Aldarweesh, Nicole Aqui, et al.
JAMA|October 12, 2023
Red Blood Cell Transfusion: 2023 AABB International GuidelinesJeffrey L Carson, Simon J Stanworth, Gordon Guyatt, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Annals of Internal Medicine|August 18, 2025
Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice GuidelinesMonica B Pagano, Simon J Stanworth, Jane Dennis, et al.
Journal of Clinical Apheresis|March 27, 2025
A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021Jeremy W Jacobs, Brian D Adkins, Garrett S Booth, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Pageof 15